METASTATIC COLORECTAL CANCER (MCRC)
Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for liver cancers: targeted chemo plus immune booster
Disease control Recruiting nowThis study tests whether adding an immune-boosting drug (PDS01ADC) to standard liver-directed chemotherapy can help people with certain cancers that have spread to the liver. About 70 adults with colorectal, bile duct, or adrenal cancer will receive treatment through a pump place…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 09:45 UTC
-
Can a targeted drug keep working after first-line failure in colorectal cancer?
Disease control Recruiting nowThis phase 3 study tests whether continuing cetuximab (a targeted therapy) along with chemotherapy after the first treatment stops working can help control metastatic colorectal cancer in patients with specific gene profiles (RAS and BRAF wild-type). About 480 adults who previous…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE3 • Sponsor: University of Campania Luigi Vanvitelli • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New combo aims to shrink Hard-to-Treat colon tumors
Disease control Recruiting nowThis study tests whether adding the experimental drug leronlimab to standard chemotherapy can shrink tumors in people with a common type of advanced colorectal cancer that has stopped responding to prior treatments. About 60 adults with microsatellite stable (MSS) metastatic colo…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New drug fruquintinib tested in Real-World colorectal cancer study
Disease control Recruiting nowThis study is observing 150 adults with metastatic colorectal cancer who have already tried standard treatments. They will take Fruquintinib as prescribed by their doctor. Researchers will track how well the drug controls the cancer, survival, side effects, and quality of life in…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
AI-Powered biopsy test could personalize colorectal cancer treatment
Diagnosis Recruiting nowThis study is testing a new diagnostic test called µCAN for people with metastatic colorectal cancer. The test uses a small sample of the tumor and combines it with artificial intelligence to find which drug might work best for each patient. Researchers want to see if the test ca…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated May 18, 2026 12:09 UTC
-
Exercise boosts Well-Being in advanced cancer patients, new trial aims to prove
Symptom relief Recruiting nowThis study looks at whether 18 weeks of guided exercise can help people with metastatic colorectal cancer feel better during chemotherapy. About 150 adults starting their first round of chemo will either join an exercise program or continue usual care. The goal is to see if exerc…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated May 26, 2026 09:30 UTC